10-123051189-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PP3_ModerateBP6

The NM_001609.4(ACADSB):​c.1128+3A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000024 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00050 ( 0 hom. )

Consequence

ACADSB
NM_001609.4 splice_region, intron

Scores

2
Splicing: ADA: 0.9999
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 2.38

Publications

1 publications found
Variant links:
Genes affected
ACADSB (HGNC:91): (acyl-CoA dehydrogenase short/branched chain) Short/branched chain acyl-CoA dehydrogenase(ACADSB) is a member of the acyl-CoA dehydrogenase family of enzymes that catalyze the dehydrogenation of acyl-CoA derivatives in the metabolism of fatty acids or branch chained amino acids. Substrate specificity is the primary characteristic used to define members of this gene family. The ACADSB gene product has the greatest activity towards the short branched chain acyl-CoA derivative, (S)-2-methylbutyryl-CoA, but also reacts significantly with other 2-methyl branched chain substrates and with short straight chain acyl-CoAs. The cDNA encodes for a mitochondrial precursor protein which is cleaved upon mitochondrial import and predicted to yield a mature peptide of approximately 43.7-KDa. [provided by RefSeq, Jul 2008]
ACADSB Gene-Disease associations (from GenCC):
  • 2-methylbutyryl-CoA dehydrogenase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 10-123051189-A-T is Benign according to our data. Variant chr10-123051189-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 299084.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACADSBNM_001609.4 linkc.1128+3A>T splice_region_variant, intron_variant Intron 9 of 10 ENST00000358776.7 NP_001600.1 P45954-1A0A0S2Z3P9
ACADSBNM_001330174.3 linkc.822+3A>T splice_region_variant, intron_variant Intron 8 of 9 NP_001317103.1 P45954-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACADSBENST00000358776.7 linkc.1128+3A>T splice_region_variant, intron_variant Intron 9 of 10 1 NM_001609.4 ENSP00000357873.3 P45954-1
ACADSBENST00000368869.8 linkc.822+3A>T splice_region_variant, intron_variant Intron 8 of 9 2 ENSP00000357862.4 P45954-2

Frequencies

GnomAD3 genomes
AF:
0.0000242
AC:
1
AN:
41316
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000261
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000415
AC:
10
AN:
24094
AF XY:
0.000583
show subpopulations
Gnomad AFR exome
AF:
0.00233
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000425
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000501
AC:
17
AN:
33902
Hom.:
0
Cov.:
0
AF XY:
0.000500
AC XY:
9
AN XY:
18004
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
736
American (AMR)
AF:
0.00
AC:
0
AN:
824
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1268
East Asian (EAS)
AF:
0.00
AC:
0
AN:
296
South Asian (SAS)
AF:
0.000642
AC:
3
AN:
4676
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1456
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
78
European-Non Finnish (NFE)
AF:
0.000599
AC:
14
AN:
23374
Other (OTH)
AF:
0.00
AC:
0
AN:
1194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.404
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000242
AC:
1
AN:
41316
Hom.:
0
Cov.:
0
AF XY:
0.0000521
AC XY:
1
AN XY:
19186
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
10488
American (AMR)
AF:
0.000261
AC:
1
AN:
3826
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3094
South Asian (SAS)
AF:
0.00
AC:
0
AN:
930
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1500
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
96
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
19276
Other (OTH)
AF:
0.00
AC:
0
AN:
570
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain:1Benign:1
Dec 03, 2017
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
16
DANN
Benign
0.77
PhyloP100
2.4

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.89
SpliceAI score (max)
0.76
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.76
Position offset: -3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760423996; hg19: chr10-124810705; API